Purdue Pharma and Sackler Family Reach Up to $7.4 Billion Settlement in Opioid Crisis Lawsuits

Purdue Pharma and Sackler Family Reach Up to $7.4 Billion Settlement in Opioid Crisis Lawsuits

1 minute read
Updated 1 month ago

Settlement Details

and the Sackler family agreed to a new settlement plan, offering up to $7.4 billion to resolve lawsuits over 's impact, aiming to abate the opioid crisis.

The Sacklers will relinquish control of Purdue and contribute significantly, while the company itself will add nearly $900 million to the settlement.

Legal and Social Repercussions

The settlement, requiring court approval, includes provisions for future lawsuits and aims to fund addiction treatment and overdose reversal medications.

The deal seeks to address the opioid crisis's toll, with the Sackler family denying wrongdoing despite facing widespread criticism and legal challenges.
This is a beta feature. We cannot guarantee the accuracy or quality of responses.